TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer says Zoetis (ZTS) , an animal health company, is well run. The company was spun off from Pfizer (PFE) , which Cramer says unlocked plenty of value for investors, but said it would have been better if Pfizer kept Zoetis. On Wednesday, Zoetis reported better than expected third quarter earnings on both the top and bottom lines. Revenue rose 2% year over year to $1.24 billion. It also raised its adjusted earnings guidance for the year.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.